openPR Logo
Press release

Harrison Clinical starts Phase III clinical trial with MARVIN

07-05-2006 04:26 PM CET | Health & Medicine

Press release from: XClinical GmbH

Harrison Clinical starts Phase III clinical trial with MARVIN

Harrison Clinical Research is a global full-service CRO that meets the highest international standards. HCR has licensed MARVIN, XClinical’s EDC-CDM System non-exclusively. In April 2006 a pivotal phase III vaccine study started, involving the screening of 1600 subjects with the objective to include 800 individuals into the study. HCR has set up the study in MARVIN and has created the e-CRF, based on the international CDISC ODM Standard, in a record period of time.
XClinical Professional Services provides technical support, the server hardware and the validated hosting environment so that HCR saves operating expense and staff in IT system administration. Thus XClinical ensures a smooth technical workflow. HCR provides for the direct maintenance of the e-CRF, the first level support for the sites, the continuous data management and the statistical evaluation of the clinical trial.

Harrison Clinical Research (www.harrisonclinical.com) provides support for all phases of clinical development and registration of new pharmaceutical products and medical devices from Phase I (Phases I and IIa in HCR ’s own clinics) to Phase IV, Monitoring, Biostatistics and Data Management, Medical Writing, Auditing and Training. HCR´s Quality Management System was awarded the ISO 9001 certification in March 1998. HCR is one of the few Clinical Research Organisations (CROs) that have achieved this. It was updated to ISO 9001:2000 in January 2002 and was renewed again in April 2004.

XClinical GmbH (www.xclinical.com) is a modern and professional Munich-based EDC vendor for all types of clinical studies. The company develops and distributes MARVIN, an Internet-based Software for Electronic Data Capture (EDC), Clinical Data Management (CDM) and Clinical Trial Management (CTM).
More and more pharmaceutical and biotechnology companies, but also medical devices manufacturers are using MARVIN, the data of more than 25,000 patients in 26 simultaneous studies have been documented until today.

Eva Boscher, XClinical GmbH, Phone: 089 / 452277-5210, Email: press@xclinical.com
Joachim Klinger, Harrison Clinical Research GmbH, Phone: +49 - 89 / 126680-2190,
Email: jklinger@harrison-cro.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Harrison Clinical starts Phase III clinical trial with MARVIN here

News-ID: 9902 • Views: 2110

More Releases from XClinical GmbH

XClinical integrates INCA, Medical Coding software, with its EDC system MARVIN
XClinical releases version 1.6. of its coding system INCA XClinical GmbH, Munich, Germany, May 8, 2014 – XClinical, a global provider of eClinical solutions, today announces the availability of INCA version 1.6, medical coding software featuring MedDRA and WHODrug dictionaries, including an automated web interface to EDC systems such as MARVIN. INCA (“Integrated Coding Architecture”) is a web-based application that enables users to classify health related data such as patient medications and
XClinical CRO Executive Forum
XClinical hosts its first CRO Executive Forum on May 10, 2011 in Aying, Germany. XClinical GmbH, Munich, Germany – April 14, 2011 – XClinical, a European vendor of innovative software products for eClinical trials known for its innovative and user-friendly CDISC ODM-certified EDC software suite MARVIN, hosts its first CRO Executive Forum especially designed for CEOs of CROs on May 10, 2011 in Aying, Germany. The concept In 2010, XClinical started to provide
XClinical’s “MARVIN4KIDS” at the DIA Geneva
XClinical presents the initiative “MARVIN4KIDS” at the DIA Annual EuroMeeting in Geneva XClinical GmbH, Munich, Germany – March 25, 2011 – XClinical, a European vendor of innovative software products for eClinical trials known for its innovative and user-friendly CDISC ODM-certified EDC software suite MARVIN, presents the initiative “MARVIN4KIDS” for the first time at the DIA Annual EuroMeeting in Geneva. The conference takes place from March 28 to 30. “MARVIN4KIDS” MARVIN4KIDS is an XClinical
XClinical and IDDI: The best of 2 worlds
The IWR/IVR system ID-netTM developed by IDDI now provides an interface to MARVIN, XClinical’s EDC system XClinical GmbH, Munich, Germany – March 25, 2011 – XClinical, a European vendor of innovative software products for eClinical trials known for its innovative and user-friendly CDISC ODM-certified EDC software suite MARVIN, presents the web-based open interface of IDDI’s ID-netTM to XClinical’s EDC system MARVIN at the DIA Annual EuroMeeting in Geneva. About ID-netTM ID-netTM

All 5 Releases


More Releases for Clinical

Clinical solutions
Are you spending more time with yellow files than with patients? Healthbridge can change that with our intuitive and easy to use clinical platform that is designed specifically for the medical practitioner at the practice. smaller2 Easily access patient information Cloud-based technology enables you to store rich clinical information that can be easily accessed as and when you need it. Medical billing software innovation Become a paperless practice Create scripts, sick notes, and clinical notes electronically. Plus, have
Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation. This is the premier interdisciplinary forum for
Clinical Trial Management System
According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019. Request Report TOC @ https://www.persistencemarketresearch.com/methodology/3017
Clinical Nutrition Conference 2018
Clinical nutrition is essential for patients in healthcare to deal with sickness, injuries, surgery and for proper recovery. It helps in preventing malnutrition, restoring body tissue and boosting energy and immunity in the body. It can be provided with a proper diet plan and feeding the patient with essential foods that revive the patient’s body the patient can also be given healthy supplements for proteins, vitamins etc. The preferred route
Clinical Communication
According to a recent market report published by Persistence Market Research titled “Clinical Communication and Collaboration Market: Global Industry Analysis (2012–2016) and Forecast (2017–2025),” revenue from the global clinical communication and collaboration market was US$ 138.5 Mn in 2012 and US$ 214.8 Mn in 2016, representing a CAGR of 11.6% from 2012 to 2016. This revenue growth is attributed to addition of new features in clinical communication and collaboration solutions.
Europe Clinical Nutrition Market
According to the report “Europe Clinical Nutrition Market,” published by Market Data Forecast, the global market is projected to reach USD 12.45 billion by 2021 from USD 9.65 billion in 2016, at a CAGR of 5.29% from 2016 to 2021. Clinical nutrition is the practice of analysing if a person is consuming an adequate amount of nutrients for good health. A clinical nutritionist is concerned with how nutrients in food are